Clinician participation in CADTH’s pan-Canadian Oncology Drug Review: contribution and impact on cancer drug funding recommendations
Abstract
-
Keywords
Oncology; Health Technology Assessment; pan-Canadian Oncology Drug Review
DOI: http://dx.doi.org/10.3747/co.24.3644
Copyright © 2018 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)